Core Viewpoint - Yongsheng Medical (01612) reported a strong interim performance for the six months ending June 30, 2025, with significant revenue and profit growth driven by its imaging disposable products segment [1] Financial Performance - The company achieved revenue of HKD 449 million, representing an 18.05% year-on-year increase [1] - Profit attributable to owners increased by 55.1% to HKD 51.629 million [1] - Basic earnings per share were HKD 0.0803 [1] Segment Performance - Revenue from the imaging disposable products segment rose by 28.6%, significantly contributing to overall revenue growth [1] - The respiratory products segment experienced a recovery in revenue, which offset the decline from the orthopedic support rehabilitation devices segment [1] Profitability Metrics - Gross profit increased by 33.4% to HKD 159 million, supported by economies of scale, improved operational efficiency, and reduced inventory provisions [1] - Gross margin improved from 31.3% to 35.4% [1]
永胜医疗发布中期业绩，股东应占溢利5162.9万港元 同比增加55.1%